Quality Assurance

Our Quality Policy stands to achieve the highest attainable level of quality in the provided analytical services to the pharmaceutical, biopharmaceutical, cell & gene therapy industry. These services include laboratory activities, reporting, project management and scientific/regulatory advice throughout the drug development process. The analytical services range from preclinical studies to release of product batches for patient supply. Through continuous process optimization, standardisation and quality trainings of all employees we aim at exceeding customer expectations. In agreement with our customers and depending on the phase of drug development, our quality mindset is sufficiently flexible to find the right balance between good analytical practices and risk-based decision making.

The independent Quality Assurance team is responsible to oversee and promote quality achievement, to ensure compliance of the quality systems with applicable (inter)national standards and legislation, to define quality policies and procedures, to set up and maintain control of documentation and to contribute to both internal and external audits.